• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Atrial Fibrillation (1729); Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Myocardial Infarction (1969); Renal Failure (2041); Shock (2072); Cardiac Tamponade (2226); Respiratory Failure (2484); Thrombosis/Thrombus (4440)
Event Date 01/01/2016
Event Type  Injury  
Event Description
This research article was a meta-analysis study designed to discuss in-hospital complications after mitraclip in patients with heart failure and preserved versus reduced ejection fraction in the united states.Complications identified in the study included: acute myocardial infarction, acute kidney injury, major bleeding requiring blood transfusion, intra-operative stroke, post-procedural shock, respiratory failure, deep vein thrombosis (dvt) or pulmonary embolism (pe), cardiac tamponade, mechanical ventilation, atrial fibrillation, hospitalization, and death.In conclusion, in the present study of us patients, those with hfref were observed to have statistically higher risk of in-hospital post-procedural shock and longer hospitalization length of stay when compared with patients with hfpef who underwent mitraclip implantation.Additionally, patients with hfref undergoing mitraclip procedure were observed to have higher absolute rates of certain post-procedural complications, however these observations did not reach statistical significance.Understanding of the aforementioned differences after mitraclip implantation may be useful in-patient selection, prognostic guidance, and hypothesis generation to propel future large clinical studies.Details are listed in the attached article titled, "in-hospital complications after mitraclip in patients with heart failure and preserved versus reduced ejection fraction in the united states".
 
Manufacturer Narrative
B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided the additional patient effect of death reported in the article is captured under a separate medwatch report.The device was not returned for analysis.The lot history record (lhr) and similar incident reviews were not performed because this incident was based on an article review and no lot information was provided.Based on available information and due to the limited information available from the article, the cause of the reported death, respiratory failure, stroke, pulmonary embolism, cardiac tamponade, myocardial infarction, renal failure, hemorrhage, shock, thrombosis, and atrial fibrillation were unable to be determined.The reported patient effects of myocardial infarction, respiratory failure, renal failure, death, cerebrovascular accident, hemorrhage, thrombosis/thrombus, and cardiac tamponade, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization, surgical intervention, and unexpected medical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.Attachment: article titled "in-hospital complications after mitraclip in patients with heart failure and preserved versus reduced ejection fraction in the united states.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18351249
MDR Text Key330815607
Report Number2135147-2023-05559
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/27/2023
Initial Date FDA Received12/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient SexFemale
-
-